Medicine recalls
|
| |
| The United States: Nutrizone expands recalls of various lots of multiple dietary supplements to include all kratom products and all lots because of possible Salmonella health risk |
| |
The US Food and Drug Administration (FDA) announces that NutriZone, LLC of Houston, Texas is expanding its recall of various kratom dietary supplements to all lots sold, which may contain the same source material as the original recalled lots. The expanded recall is being conducted out of an abundance of caution. The products are (all Net Quantity, Lot Number and Packaging):
- Cali Green Malay
- Cali Maeng Da
- Cali Thai
- Nirvanio Bali
- Nirvanio Green Malay
- Nirvanio Maeng Da
- Nirvanio Special Reserve
- Pain Out Green Malay
- Pain Out Maeng Da
- Pain Out Thai
The products were sold nationwide. No illnesses have been reported to date in connection with this problem. The potential for contamination was noted after routine sampling and testing by the FDA revealed the presence of Salmonella.
The recall of dietary supplements is due to the potential for contamination with Salmonella. Salmonella, is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy people infected with Salmonella should monitor themselves for some or all of the following symptoms: nausea, vomiting, diarrhea or bloody diarrhea, abdominal cramping and fever. Rarely, Salmonella can result in more serious ailments, including arterial infections, endocarditis, arthritis, muscle pain, eye irritation, and urinary tract symptoms. Consumers exhibiting these signs after having contact with this product should contact their healthcare providers.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/Recalls/ucm603356.htm
In Hong Kong, the above products are not registered pharmaceutical products. There is also no registered pharmaceutical product containing kratom. Related news was previously issued by FDA, and was posted on the Drug Office website on 4 Apr 2018, 19 Apr 2018 and 21 Apr 2018.
Ends/Tuesday, Apr 24, 2018
Issued at HKT 15:00
|
| |
|
